Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China
· Delayed Price · Currency is CNY 26.83
+0.20 (0.75%)
May 13, 2025, 3:00 PM CST
SHA:600332 Revenue
Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 22.47B CNY in the quarter ending March 31, 2025, a decrease of -2.06%. This brings the company's revenue in the last twelve months to 74.52B, down -3.01% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.
Revenue (ttm)
74.52B
Revenue Growth
-3.01%
P/S Ratio
0.55
Revenue / Employee
2.65M
Employees
28,048
Market Cap
41.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74.99B | -522.58M | -0.69% |
| Dec 31, 2023 | 75.52B | 4.73B | 6.68% |
| Dec 31, 2022 | 70.79B | 1.77B | 2.57% |
| Dec 31, 2021 | 69.01B | 7.34B | 11.90% |
| Dec 31, 2020 | 61.67B | -3.28B | -5.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |